From: CDK5: an oncogene or an anti-oncogene: location location location
No | Cancer Types | CDK5 status | CDK5 activator status | CDK5 localization | CDK5 functions | References |
---|---|---|---|---|---|---|
1 | Breast cancer | Overexpressed | p35 overexpressed | Cytoplasmic/membranous* | Proliferation, cell survival, EMT and metastasis | |
2 | Prostate cancer | Overexpressed | p35 overexpressed | Predominantly Cytoplasmic/membranous, little nuclear staining* | Proliferation, migration, invasion, metastasis and neuroendocrine differentiation | |
3 | Pancreatic cancer | Overexpressed | p35 and p39 overexpressed | Predominantly Cytoplasmic/membranous, little nuclear staining* | Proliferation, tumorigenesis, migration and metastasis | |
4 | Medullary thyroid cancer | Overexpressed | p35 and p25 overexpressed | Cytoplasmic/membranous* | Proliferation and tumorigenesis | [34] |
5 | Gastric cancer | Decreased | p35 low | Excluded from nucleus [41] | Inhibits proliferation and metastasis. Acts as cell cycle suppressor | |
6 | Colorectal cancer | Overexpressed | p35 overexpressed | Cytoplasmic/membranous* | Proliferation, migration and invasion | |
7 | Glioma | Overexpressed | p35 and p25 overexpressed | Predominantly cytoplasmic with some nuclear staining [68, 69] | Tumorigenesis, migration and invasion | |
8 | Hepatocellular carcinoma | Overexpressed | p35 overexpressed | Cytoplasmic/membranous/nuclear* | Tumorigenesis, angiogenesis and metastasis | |
9 | Pituitary adenoma | Overexpressed | p35 overexpressed | Cytoplasmic [86] | Migration and invasion | |
10 | Lung Cancer | Overexpressed | p35 overexpressed | Cytoplasmic | Tumorigenesis, metastasis, tumor immunity, radio- and chemoresistance | |
11 | Melanoma | Overexpressed | p35 overexpressed | Cytoplasmic/membranous* | Tumorigenesis, invasion and metastasis | |
12 | Ovarian cancer | Overexpressed | - | Inhibits cell cycle arrest and apoptosis | ||
13 | Medulloblastoma | Overexpressed | p35 and p39 overexpressed | - | Immune evasion | [103] |
14 | Head and neck cancer | Overexpressed | - | Predominantly cytoplasmic/membranous, some nuclear* | EMT, invasion and metastasis | [108] |
15 | Leukemia | mRNA upregulated and downregulated | p35 and Cyclin I mRNA upregulated | - | Survival and proliferation | |
16 | Multiple Myeloma | Overexpressed | - | - | Proliferation and drug resistance |